Thanks for the update. I checked into it. INVO has submitted requested clinical data to the FDA, which the agency is reviewing as part of their approval process. No defined timeline on the FDA's decision, but clearly this could be a huge milestone for INVO if they receive FDA clearance for the procedure in the U.S. From a bigger picture perspective, global fertility rates on on the decline (with the exception of emerging markets like Africa) so there is a large market for a cheaper alternative to IVF, and the INVO procedure has demonstrated comparable, safe results. From an investor perspective, with a market cap of less than $5 million IVOB looks very attractive with huge upside potential IMO.